MedPath

The efficacy of DAAs against the patients with chronic hepatitis and cirrhosis due to HCV

Not Applicable
Recruiting
Conditions
the patients with chronic hepatitis and cirrhosis due to HCV
Registration Number
JPRN-UMIN000018098
Lead Sponsor
Shinanomachi Liver Conference
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

inadequate patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SVR rate
Secondary Outcome Measures
NameTimeMethod
adverse event
© Copyright 2025. All Rights Reserved by MedPath